Stay updated on Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial page.

Latest updates to the Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of a clinical trial for NC-6004 in combination with pembrolizumab, and the update of the revision number from v2.14.4 to v2.15.0.SummaryDifference17%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial page.